The glucocorticoid receptor (GR) is an important anti-cancer target in lymphoid cancers but has been understudied in solid tumors like lung cancer. although glucocorticoids are often given with chemotherapy regimens to mitigate side effects. Here. we identify a dexamethasone-GR mediated anti-cancer response in a subset of aggressive non-small cell lung cancers (NSCLCs) that harbor Ser... https://www.incredibleindiatourtravels.com/